Developer of radiopharmaceutical products. The company develops in-vivo radiopharmaceutical products suitable for Nuclear Medicine (SPECT) imaging that will aid in the early diagnosis and management of diseases including rheumatoid arthritis.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore AAA‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.